Can patients experience remission of asthma, especially those with childhood-onset mild intermittent asthma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can People Outgrow Asthma?

Yes, some people do experience remission of asthma, particularly those with childhood-onset disease, but the majority (approximately 60%) will have persistent asthma into adulthood, and even those in apparent remission often retain underlying airway inflammation and risk of relapse.

Understanding Asthma Remission vs. "Outgrowing"

The concept of "outgrowing" asthma is better understood as clinical remission—a state characterized by absence of symptoms and exacerbations without medication use for an extended period (typically ≥3 years). However, this is not equivalent to cure 1, 2.

Key Evidence on Remission Rates

In childhood-onset asthma followed longitudinally:

  • Only 21% achieved remission by age 19 years (defined as no medication use and no wheeze for ≥3 years) 3
  • 62% had persistent asthma when followed from age 8 to 28 years 4
  • Among those achieving remission, 38% had periodic asthma with intermittent symptoms 3

Who Is Most Likely to Achieve Remission?

Strong Predictors of Remission (Favorable):

  • Male sex (boys more likely than girls to achieve remission) 3
  • Milder asthma severity at diagnosis (asthma score <2) 3
  • Absence of allergic sensitization, particularly to furred animals 3
  • Higher baseline lung function 1, 2
  • Younger age at asthma onset 5, 1
  • Shorter duration of disease 1

Strong Predictors of Persistent Asthma (Unfavorable):

  • Allergic sensitization to animals (OR 0.14 for remission, meaning 86% less likely) 3
  • More severe asthma at age 7-8 years (OR 0.19 for remission) 3
  • Female gender 3, 4
  • Bronchial hyperreactivity at age 17 years (OR 9.0 for persistent asthma at age 28) 4
  • Severe respiratory infections in childhood (OR 2.6 for persistence) 4
  • Rhinoconjunctivitis (OR 3.4 for persistence) 4

Critical finding: Children with both severe asthma (score ≥2) AND sensitization to furred animals had an 82% probability of persistent asthma through adolescence 3.

The Pathophysiology Reality

Even in apparent clinical remission, persistent abnormalities remain 1, 2, 6:

  • Ongoing airway inflammation is common in asymptomatic individuals with asthma history
  • Airway remodeling can be demonstrated on bronchial biopsies in young adults who believe they've "outgrown" asthma 6
  • This explains the high risk of relapse at any time, even after years of remission

Clinical Implications for Counseling Patients

For Mild Childhood Asthma:

Inform families that approximately 20-40% of children may achieve sustained remission by late adolescence/early adulthood, particularly if:

  • The child is male
  • Asthma is mild at onset
  • No significant allergic sensitization (especially to animals)
  • Good lung function is maintained

For Moderate-Severe or Allergic Asthma:

Be realistic that 60-80% will have persistent disease requiring ongoing management. The presence of:

  • Allergic sensitization to perennial allergens
  • More severe symptoms at diagnosis
  • Female gender
  • Bronchial hyperreactivity

...makes true remission unlikely.

Treatment Considerations

Current Evidence on Treatment-Induced Remission:

The 2020 NAEPP guidelines 7 and recent research 5, 1 suggest that while spontaneous remission occurs as part of natural history, there is emerging evidence that:

  • Biologic therapies may achieve on-treatment remission criteria in subgroups of patients 5, 1
  • Early intervention with inhaled corticosteroids in high-risk young children (ages 2-3 with positive asthma predictive index) was studied in the PEAK trial 8, though results on altering natural history remain inconclusive
  • The IMPACT trial 8 showed that in mild persistent asthma, intermittent treatment may be as effective as daily controller therapy, suggesting the disease may be mild enough not to require continuous suppression

Important Caveat:

No current evidence demonstrates that early or aggressive treatment can induce remission or prevent persistent asthma in those destined to have it based on their risk profile 9, 1, 2. The CAMP study showed that early inhaled corticosteroid treatment did not prevent progression or alter long-term outcomes 9.

Practical Monitoring Approach

For children with asthma, assess remission likelihood by evaluating:

  1. Severity at diagnosis (use validated asthma severity scores)
  2. Allergic sensitization status (skin prick testing, particularly for animals)
  3. Gender (males have better prognosis)
  4. Lung function trajectory (spirometry at ages 17-19 years)
  5. Bronchial hyperreactivity (if available, strong predictor)

Bottom line: Set realistic expectations. Most children with asthma, especially those with allergic sensitization and moderate-severe disease, will require ongoing management into adulthood. True remission occurs in a minority, and even then, underlying airway abnormalities often persist with risk of relapse.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.